MOLECULAR BIOLOGY REPORTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2019-03-22 124831fcm96暂无昵称

投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表:
审稿速度还可以，专家意见中肯

李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯

215 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2022-02-15 fireblue1978

转投的，一般送审后20天有结果，二审送审20天接受!

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2021-12-28 桑晒麦拉

我们做研究时最常见或撰写的SCI文章类型是什么？

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2021-12-28 rayms

常见的SCI文章类型有哪些？

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2021-12-24 12246ba1m03(暂无昵称)

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：分子生物学;miRNA;j基础
经验分享：投稿接受4个月，返修完一周内接受

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2021-10-24 ms1000001679820316

偏重的研究方向：SNP
经验分享：3号提交的，慌张还没消息

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2020-04-01 ruiruima

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept

198 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-10-06 乘风去翱翔来自甘肃省

09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。

35 0

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-09-18 ms5000001814151417 来自甘肃省

请问peer review 是什么意思呀，找到审稿人了吗

43 0

[GetPortalCommentsPageByObjectIdResponse(id=568475, encodeId=6a905684e506, content=投稿了，编辑要求润色，这接受的希望大不大？李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, beContent=李沐阳 2018-12-22 00:00:00 发表: 审稿速度还可以，专家意见中肯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a322493528, createdName=124831fcm96暂无昵称, createdTime=Fri Mar 22 00:00:00 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193698, encodeId=1ebd119369849, content=转投的，一般送审后20天有结果，二审送审20天接受! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec141702245, createdName=fireblue1978, createdTime=Tue Feb 15 19:19:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095152, encodeId=f9021095152d6, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095151, encodeId=e0701095151e4, content=常见的SCI文章类型有哪些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083956, encodeId=3a031083956a3, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学;miRNA;j基础 经验分享：投稿接受4个月，返修完一周内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bb62319102, createdName=12246ba1m03(暂无昵称), createdTime=Fri Dec 24 16:24:43 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063396, encodeId=f9ed10633960f, content=偏重的研究方向：SNP 经验分享：3号提交的，慌张还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90855519964, createdName=ms1000001679820316, createdTime=Sun Oct 24 10:13:28 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587858, encodeId=c01d58e85838, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-15, submit a review, 2020-2-17,demand major revise 2020-3-27,submit a revised review 2020-3-31,Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161152, encodeId=acd52161152f6, content=09.26邀请了5位审稿人，到现在没有1位接受审稿，半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/3911228CA2746F0F2424334C576FE130/100, createdBy=1ebd2052201, createdName=乘风去翱翔, createdTime=Fri Oct 06 09:39:50 CST 2023, time=2023-10-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2158296, encodeId=70822158296bf, content=请问peer review 是什么意思呀，找到审稿人了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77bf5647275, createdName=ms5000001814151417, createdTime=Mon Sep 18 15:14:39 CST 2023, time=2023-09-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2125942, encodeId=2df62125942b3, content=Editor Assignment Pending四天了，什么情况？没有编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:41:18 CST 2023, time=2023-04-14, status=1, ipAttribution=天津)]

2023-04-14 ms7000000431018817 来自天津

Editor Assignment Pending四天了，什么情况？没有编辑吗

39 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务